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BACKGROUND: Plasma D-dimer levels are directly related to the intra- and extra-vascular coagulation that occurs in acute and 
chronic lung damage in patients with community-acquired pneumonia (CAP). 
OBJECTIVES: This study examines the relationship between the severity of community-acquired pneumonia and D-dimer levels. 
In addition, the study examines the correlations among community-acquired pneumonia, the radiological extent of the disease and 
mortality. 
METHODS: The Pneumonia Severity Index was used to classify patients into five groups. Patients were treated at home or in the 
hospital according to the guidelines for community-acquired pneumonia. Blood samples were taken from the antecubital vein with 
an injector and placed into citrated tubes. After they were centrifuged, the samples were evaluated with the quantitative latex method. 
RESULTS: The study included 60 patients who had been diagnosed with community-acquired pneumonia (mean age 62.5 ± 11.7) 
and 24 healthy controls (mean age 59.63 ± 6.63). The average plasma D-dimer levels were 337.3 ± 195.1ng/mL in the outpatient 
treatment group, 691.0 ± 180.5 in the inpatient treatment group, 1363.2 ± 331.5 ng/mLin the intensive care treatment group and 
161.3 ± 38.1ng/mL in the control group (p<0.001). The mean D-dimer plasma level was 776.1 ± 473.5ng/mL in patients with an 
accompanying disease and 494.2 ± 280.1 ng/mL in patients without an accompanying disease (p<0.05). 
CONCLUSIONS: Plasma D-dimer levels were increased even in community-acquired pneumonia patients who did not have an 
accompanying disease that would normally cause such an increase. 
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INTRODUCTION
Community-acquired pneumonia (CAP) is acquired 
during the course of everyday life by patients who do not 
have a known immune deficiency. Despite advancements 
in antibiotic treatment, CAP continues to negatively affect 
morbidity and mortality. CAP is also the sixth most common 
infectious cause of death in hospitals.1 Previous studies have 
shown that the mortality rate of pneumonia varies from 1% 
to 60% and is related to the weight of the patient.2 Studies 
have found that the mortality rate in CAP outpatient cases is 
1-5%; the mortality rate is 12% in inpatient cases and 40% 
in intensive care patients.3,4 
D-dimer (DD) is a metabolic substance produced during 
the catabolization of fibrin by plasmin. DD levels have 
been shown to increase in patients who have disorders that 
trigger fibrin production and catabolization; these disorders 
include pulmonary emboli (PE), deep vein thrombosis 
(DVT), solid tumors, leukemia, severe infections, trauma or 
a post-operative state, disseminated intravascular coagulation 
(DIC), pregnancy, acute stroke, sickle-cell anemia, 
congestive heart failure and chronic kidney failure.5-8 While 
the measurement of plasma DD levels is a well-known test 
for venous thromboemboli, the relationship between plasma 
DD and other diseases is still unclear. A limited number of 
studies have examined the relationship between CAP and 
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plasma DD levels. Some of these studies suggest that an 
increase in DD is directly related to the intra- and extra-
vascular coagulation that occurs in acute and chronic lung 
damage in CAP cases.9 
The present study investigated the relationship between 
the severity of CAP and serum DD levels, as well as 
the potential correlation among plasma DD levels, the 
radiological extent of the disease and hospital mortality 
rates. The ultimate goal of this study was to determine 
whether plasma DD levels can be used to develop prognoses 
in CAP cases.
MATERIALS AND METHODS
This study began in October 2007-June 2008 at the 
Department of Chest Diseases, Faculty of Medicine, 
Cumhuriyet University, Sivas, Turkey, and included 60 
consecutive CAP patients and 24 healthy controls. The 
study was approved by the ethics committee of the Faculty 
of Medicine, Cumhuriyet University, and all participants 
gave their informed consent. Individuals were excluded 
from the study because of cancer, leukemia, known blood-
clotting and bleeding disorders, disseminated intravascular 
coagulation (DIC), renal failure, rheumatological diseases, 
vasculitis or sickle-cell anemia, pregnancy, an age less than 
18 years or thromboembolic diseases . The demographic 
characteristics, physical examination findings and laboratory 
findings (leucocytes, hemoglobin, hematocrit, glucose, 
sodium, potassium, urea, creatinine, CRP and sedimentation) 
of all study participants were monitored regularly. Initial lung 
X-rays were taken for all patients in the CAP group and the 
control group. Patients were placed into two groups according 
to their lung X-rays: lobar (i.e., more than one segment of the 
same lobe involved) and multilobar (i.e., more than one lobe 
involved). Patients were divided into five groups according to 
the Pneumonia Severity Index (PSI) (PSI groups I, II, III, IV 
and V).10,11 CAP guidelines were used to determine whether 
patients would be treated at home or in the hospital.12 The 
criteria are shown in Table 1. The plasma DD levels of all 
participants were measured in the hospital’s hematology 
laboratory before starting the treatments of their CAP. 
Blood samples taken from the antecubital vein with an 
injector were placed into 1.8 mL citrated tubes. The blood 
samples were centrifuged at 40,000 rpm for 15 minutes at 
room temperature and then evaluated using the quantitative 
latex method (ACLTOP, Italy). Plasma DD levels over 232 
ng/mL were considered to be high. Statistical analyses were 
conducted with SPSS (version 14) for Windows. Kruskal-
Wallis (CV), Tukey’s and Mann-Whitney U tests were used 
in the statistical analyses, and p-values of less than 0.05 were 
accepted as significant.
RESULTS
The study included 60 CAP patients with an overall 
mean age of 62.5 ± 11.7 years (29 males with an average age 
of 63.0 ± 11.7 years and 31 females with an average age of 
62.0 ± 11.7 years) and 24 healthy controls with a mean age 
of 59.6 ± 6.6 years (10 males with an average age of 59.5 ± 
4.6 years and 14 females with an average age of 59.4.0 ± 7.9 
years). The age and sex distributions for the CAP and control 
groups are shown in Table 2.
Table 1 - Hospital Admission Criteria in Patients with CAP.
Patient Type Criteria
Outpatients Patients in PSI categories I and II
Outpatients (home 
treatment under 
observation)
Patients in PSI category III
Patients in PSI categories I and II with a 
comorbidity
Inpatients (conventional
hospitalization)
Patients in PSI categories IV and V
Patients in any PSI class who have signifi-
cant pleural effusion
Multilobar involvement
Uncontrolled COPD (i.e., respiratory rate > 
30 breaths/min or PO2 < 50 mm Hg)
Acute respiratory failure (i.e., respiratory 
rate > 30 breaths/min or PO2 <60 mm Hg)
Chronic renal failure (i.e., creatinine level > 
2 mg/dL)
Liver failure (child > 5 points)
Alcohol abuse
Lack of family support
Psychosocial problems
Uncontrolled coexisting disease
Inpatients (ICU) Respiratory failure requiring mechanical 
ventilation
Severe hypotension (systolic BP < 90 mm 
Hg) with oliguria
Renal failure requiring dialysis
Coma
Septic complications
Table 2 - Demographic characteristics.
Outpatient
Pneumonia
n=24
Inpatient
Pneumonia
N=25
Intensive Care
Pneumonia
n=11
Control
Group
n=24
p value
Mean Age (years)
Sex (F/M)
63.67±15.2
14/10
60.75±12.8
12/13
66.05±10.3
6/5
59.6±6.6
14/10
0.089
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The relationship between plasma DD levels and PSI was 
found to be statistically significant (p<0.05). Statistically 
significant differences (p<0.05) were found between the 
following groups: the control group and PSI groups III, IV 
and V; PSI group I and PSI group IV and V; PSI group III 
and PSI group V as well as between PSI group IV and PSI 
group V. Differences between the other groups were not 
found to be statistically significant (p>0.05) (Table 3).
Kruskal-Wallis (CV): 66.57, p<0.05. Statistically 
significant (p<0.05) differences were found between the 
following groups: the Control Group and PSI group III, IV 
and V; PSI group I and PSI group IV and V; PSI group II and 
PSI group IV and V; PSI group III and PSI group IV as well 
as between PSI group IV and PSI group V. No statistically 
significant differences were found among the other classes 
(p>0.05). 
Plasma DD levels were 337 ± 195.1ng/mL in the 
outpatient group, 691.0 ± 180.5ngmL in the Inpatient Group, 
1363.2 ± 331.5ng/mL in the Intensive Care Group and 161.3 
± 38.1ng/mL in the Control Group (see Table 4 and Figure 
1).
In addition to CAP, 38 patients had other accompanying 
diseases (15 patients: asthma/COPD (Chronic obstructive 
pulmonary disease) 9 patients: diabetes mellitus; 8 patients: 
coronary artery disease; 3 patients: chronic liver disease and 
3 patients: peptic ulcus); 22 patients had no accompanying 
disease. The mean plasma DD level for patients who had 
an accompanying disease was 776.15 ± 473.58, while the 
mean serum DD level for patients without an accompanying 
disease was 494.23 ± 280.18 ng/mL.
Patients were divided into two groups (lobar and 
multilobar), and plasma DD levels in the multilobar group 
were significantly higher than those in the lobar group (Table 
5) (p<0.001) 
 
Five of the 36 inpatients (13.8%) died; all of the 
deceased patients had plasma DD levels that were higher 
than the normal limit (1429.8 ± 511.3ng/mL), and all had 
another disease in addition to CAP. 
DISCUSSION
An increase in plasma DD levels may result from 
the activation of the fibrinolytic system and from fibrin 
catabolization within the alveoli. In addition, plasma DD 
levels may be increased by the activation of the blood 
coagulation process; this activation is caused by endotoxins 
in the Gram-negative pathogens that trigger CAP.12-15 
This study found that the plasma DD levels of CAP 
outpatients, inpatients and intensive care patients correlated 
positively with the severity of their pneumonia. Plasma 
DD levels were also higher in CAP patients than in healthy 
controls. 
The PSI is commonly used to evaluate disease severity 
in CAP patients. This study found a statistically significant 
relationship between patients’ PSI scores and their plasma 
DD levels. Shilon et al.,16 in a study performed on 68 CAP 
patients and no control group, found that PSI groups IV and 
V were associated with increased plasma DD levels when 
compared with groups I, II and III. Guneysel et al.17 studied 
51 CAP patients and a healthy control group. They found 
Table 3 - Serum DD levels according to PSI.
PSI DD (ng/mL)
Group I n=6 191.5 ± 81.9
Group II n=10 318.0 ± 174.7
Group III n=8 470.9 ± 204.6
Group IV n=21 657.2 ± 144.5
Group V n=15 1231.2 ± 380.9
Control Group n=24 161.3 ±38.1
Table 4 - Plasma DD levels in patient and control groups.
 
DD (ng/mL) p value
Outpatients 337.3 ± 195.1
Inpatients 691.0 ± 180.5 0.000
Intensive Care Patients 1363.2 ± 331.5
Control Group 161.3 ± 38.1
CV:69.43, p<0.05
Figure 1 - Plasma DD levels in patient and control groups.
Table 5 - Extent of pneumonia and plasma DD levels.
 
DD (ng/mL) P value
Lobar 366.6 ± 214.5 0.000
Multilobar 821.2 ± 429.8
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mean DD levels of 2438.1 ± 2158.1 ng/mL in the Severe 
Pneumonia Group, 912.6 ± 512.6 ng/mL in the Non-severe 
Pneumonia Group and 387.94 ± 99.56 ng/mL in the Control 
Group; their results were statistically significant.17 Ribelles et 
al.18 found that increased plasma DD levels were correlated 
with PSI; their results were also statistically significant. 
Chalmers and coworkers19 also found that increased DD 
levels were correlated with PSI. In their study, median DD 
levels were as follows: Class I: 543 ng/mL; Class II: 727 ng/
mL; Class III: 1192 ng/mL; Class IV: 1128 ng/mL and Class 
V: 1801 ng/mL; p<0.001. 
The present study also found a statistically significant 
relationship between serum DD level and PSI score; these 
findings are consistent with the findings of previous studies. 
Plasma DD levels were found to be statistically 
significant in the inpatient Group than outpatients group 
(defined according to the CAP guidelines).12 Guneysel et 
al. and Ribelles et al. found increased plasma DD levels in 
intensive care patients,17,18 and Shillon et al. found increased 
plasma DD levels in inpatients.16 The present study also 
found that plasma DD levels were significantly increased in 
intensive care patients. 
Several studies have examined the relationship between 
plasma DD levels and the extent of disease in the lungs of 
CAP patients.18,20 Levi et al.20 reported a correlation between 
the extent of pulmonary disease, radiological appearance and 
plasma DD levels in severe pneumonia patients. Ribelles et 
al.18 suggested that plasma DD levels were higher in patients 
with lobar or multilobar pneumonia than in patients with 
segmental pneumonia. No relationship was detected between 
a high plasma DD level and either the radiological extent 
of the disease, microorganisms present or the antibiotics 
previously administered No segmental involvement was 
determined in the present study. This could be because 
patients came to our hospital only in the later stages of the 
illness or because they had received treatment previously 
in other healthcare settings. Patients were divided into two 
groups (lobar and multilobar), and plasma DD levels in the 
multilobar group were significantly higher than those in the 
lobar group (p<0.05). 
Ribelles et al. found a strong correlation between the 
mortality rate and serum DD levels in CAP patients18. 
While the mean serum DD level was 3,786 ± 2,646 ng/mL 
in patients who died, it was only 1,609 ± 1,808 ng/mL in 
patients who survived (p <0.0001).18 They also determined 
that CAP patients in PSI classes IV and V who had plasma 
DD levels higher than 2000 ng/mL had a higher risk of 
mortality.18 Some researchers have suggested that increased 
plasma DD levels are related to the extent of pneumonia 
because the PSI and APACHE II score are closely associated 
with the mortality rate.21 Low plasma DD levels in CAP 
patients (less than 500 ng/mL) at the time of admission to 
the hospital has been linked to a decreased likelihood of 
an early death or major morbidity.19 Several researchers 
have identified meaningful relationships between plasma 
DD levels and PSI.16,17 However, because these studies 
included an insufficient number of patients, no strong 
relationship between plasma DD levels and mortality could 
be identified.16,17 The present study was able to identify a 
strong relationship between plasma DD levels and the rate 
of mortality (13.8%).
CONCLUSION
CAP patients show increased plasma DD levels even in 
the absence of an accompanying disease that can increase 
DD levels. Increased plasma DD levels in CAP patients 
were correlated with the severity of the disease, the 
radiological extent of the disease and in-hospital mortality 
rates. Additional studies with more patients are needed to 
determine whether plasma DD levels can be used to develop 
prognoses for cases of pneumonia. 
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